A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus
Clinical trial NCT04552470 · COMPLETED
Trial details
- NCT number
- NCT04552470
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2021-03-25
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.